Extended-lister

Coronavirus Archive

Nothing was found.

Showing 81 - 90 of 96 entries

  1. MSCI Blog

    Apr 1, 2020

    Could coronavirus lead to default contagion in CLOs?

    View

  2. MSCI Blog

    Mar 31, 2020

    The end of an era for the bond-equity relationship?

    View

  3. MSCI Blog

    Mar 27, 2020

    Managing risk-model uncertainty through a crisis

    View

  4. MSCI Blog

    Mar 26, 2020

    ‘Nowcasting’ private equity in the coronavirus crisis

    View

  5. MSCI Blog

    Mar 25, 2020

    How could coronavirus impact credit markets?

    View

  6. MSCI Blog

    Mar 25, 2020

    Asset allocation and index futures during market crises

    View

  7. MSCI Blog

    Mar 24, 2020

    Updating the MSCI Agency MBS model for the COVID-19 crisis

    View

  8. MSCI Blog

    Mar 20, 2020

    How coronavirus could hurt Chinese consumer ABS

    View

  9. MSCI Blog

    Mar 18, 2020

    Real estate is about more than location during uncertain times

    View

  10. Research Paper

    Mar 16, 2020

    COVID-19 outbreak highlights gaps in Indian pharma’s quality management

    The coronavirus outbreak has applied supply chain shocks to companies relying on China for their raw materials and key supplies. The outbreak has thrown questions of quality management and resilience into sharp relief for Indian pharma companies that could have significant repercussions on the supply of medicines globally. India is the largest provider of generic drugs globally, and generic drugs account for 20% of global exports in terms of volumes. This report explores the...

    View  |  Related Products: ESG Products & Services

Showing 81 - 90 of 96 entries